Improvement of treatment in ulcerative colitis, severe case and moderate case close to severe case, by early use of infliximab

Improvement of treatment in ulcerative colitis, severe case and moderate case close to severe case, by early use of infliximab - Early use of infliximab in severe case and moderate case close to severe case of ulcerative colitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020402

Enrollment

Registered

2015-12-30

Start date

2010-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Ulceraive colitis, severe case or moderate case close to severe case, who is naive to biologics

Exclusion criteria

Exclusion criteria: mild case, moderate case close to mild case

Design outcomes

Primary

Measure	Time frame
Remission rate at 6 weeks after the initiation of treatment	—

Countries

Japan

Contacts

Public ContactTakenori Kawakami

Akita city Hospital General Administration Division

mchiba@m2.gyao.ne.jp0188234171

Outcome results